{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:14:54Z","timestamp":1789748094104,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013050","name":"Guangdong Provincial Applied Science and Technology Research and Development Program","doi-asserted-by":"publisher","award":["2021A1515220011"],"award-info":[{"award-number":["2021A1515220011"]}],"id":[{"id":"10.13039\/501100013050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8217070298"],"award-info":[{"award-number":["8217070298"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773283"],"award-info":[{"award-number":["81773283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.apsb.2024.06.004","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T19:48:25Z","timestamp":1718221705000},"page":"1211-1229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Intravenous delivery of STING agonists using acid-sensitive polycationic polymer-modified lipid nanoparticles for enhanced tumor immunotherapy"],"prefix":"10.1016","volume":"15","author":[{"given":"Ying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8193-4292","authenticated-orcid":false,"given":"Ruizhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0228-904X","authenticated-orcid":false,"given":"Zhiqing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.06.004_bib1","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2024.06.004_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2024.06.004_bib3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41591-019-0421-7","article-title":"A safe and potent anti-CD19 CAR T cell therapy","volume":"25","author":"Ying","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2024.06.004_bib4","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.apsb.2020.05.008","article-title":"Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.06.004_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jconrel.2023.11.051","article-title":"OX40L-expressing M1-like macrophage exosomes for cancer immunotherapy","volume":"365","author":"Yu","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.06.004_bib6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.apsb.2022.11.013","article-title":"An mRNA vaccine elicits STING-dependent antitumor immune responses","volume":"13","author":"Chen","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.06.004_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.apsb.2021.05.031","article-title":"Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.06.004_bib8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Sade-Feldman","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.06.004_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13073-018-0598-2","article-title":"Acquired mechanisms of immune escape in cancer following immunotherapy","volume":"10","author":"Iorgulescu","year":"2018","journal-title":"Genome Med"},{"key":"10.1016\/j.apsb.2024.06.004_bib10","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8\u03b1+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2024.06.004_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cytogfr.2015.01.001","article-title":"New perspectives on type I IFNs in cancer","volume":"26","author":"Gajewski","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.apsb.2024.06.004_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature23477","article-title":"Identification of essential genes for cancer immunotherapy","volume":"548","author":"Patel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.06.004_bib13","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1021\/acs.jmedchem.9b01039","article-title":"Targeting stimulator of interferon genes (STING): a medicinal chemistry perspective","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.06.004_bib14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor\u00a0that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.06.004_bib15","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200844","article-title":"STING agonist promotes CAR T cell trafficking and in breast cancer","volume":"218","author":"Xu","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2024.06.004_bib16","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.apsb.2021.12.010","article-title":"Tetrahedral DNA nanostructures synergize with MnO2 to enhance antitumor immunity via promoting STING activation and M1 polarization","volume":"12","author":"Liang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.06.004_bib17","article-title":"Multifunctional mesoporous polydopamine-based systematic delivery of STING agonist for enhanced synergistic photothermal-immunotherapy","volume":"34","author":"Zeng","year":"2024","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2024.06.004_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111003119","article-title":"STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models","volume":"119","author":"Berger","year":"2022","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.004_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.06.004_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.06.004_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2024.06.004_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING Agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2024.06.004_bib23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41565-022-01225-x","article-title":"Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration","volume":"17","author":"Yang","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2024.06.004_bib24","doi-asserted-by":"crossref","first-page":"15977","DOI":"10.1021\/acsnano.2c03509","article-title":"Activating innate immunity by a STING signal amplifier for local and systemic immunotherapy","volume":"16","author":"Song","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.06.004_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120638","article-title":"A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer","volume":"3","author":"Cheng","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2024.06.004_bib26","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jconrel.2020.11.017","article-title":"Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration","volume":"330","author":"Wehbe","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.06.004_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jconrel.2022.03.054","article-title":"Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy","volume":"345","author":"Doshi","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.06.004_bib28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41563-022-01251-z","article-title":"STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity","volume":"21","author":"Dane","year":"2022","journal-title":"Nat Mater"},{"key":"10.1016\/j.apsb.2024.06.004_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Sahay","year":"2022","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2024.06.004_bib30","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2024.06.004_bib31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS\u2013STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2024.06.004_bib32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/bm701301s","article-title":"Zwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasma","volume":"9","author":"Ladd","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.apsb.2024.06.004_bib33","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1021\/la302433a","article-title":"Superhydrophilic zwitterionic polymers stabilize liposomes","volume":"28","author":"Cao","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.apsb.2024.06.004_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41565-018-0342-5","article-title":"Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy","volume":"14","author":"Shae","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2024.06.004_bib35","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.ymthe.2018.08.022","article-title":"Therapeutic potential of OMe-PS-miR-29b1 for treating liver fibrosis","volume":"26","author":"Kumar","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2024.06.004_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2023.08.039","article-title":"Surface-tethered ROS-responsive micelle backpacks for boosting mesenchymal stem cell vitality and modulating inflammation in ischemic stroke treatment","volume":"362","author":"You","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.06.004_bib37","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.cclet.2020.03.001","article-title":"pH-Sensitive nanoscale materials as robust drug delivery systems for cancer therapy","volume":"31","author":"Shi","year":"2020","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2024.06.004_bib38","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.apsb.2022.03.015","article-title":"Broad-spectrum and powerful neutralization of bacterial toxins by erythroliposomes with the help of macrophage uptake and degradation","volume":"12","author":"Liu","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.06.004_bib39","series-title":"Winston-Salem, North Carolina: Biomedical Engineering","article-title":"Nanoparticle-STING agonist enhances the tumoricidal effect of bone marrow-derived macrophage","author":"Yuan","year":"2021"},{"key":"10.1016\/j.apsb.2024.06.004_bib40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","article-title":"A programmable encapsulation system improves delivery of therapeutic bacteria in mice","volume":"40","author":"Harimoto","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2024.06.004_bib41","article-title":"Measurement of bacterial ingestion and killing by macrophages","volume":"109","author":"Drevets","year":"2015","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.apsb.2024.06.004_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2024.06.004_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri.2017.28","article-title":"Monocyte differentiation and antigen-presenting functions","volume":"17","author":"Jakubzick","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2024.06.004_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12399","article-title":"Uptake of extracellular vesicles into immune cells is enhanced by the protein corona","volume":"12","author":"Dietz","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2024.06.004_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41565-020-0643-3","article-title":"Targeted crystallization of mixed-charge nanoparticles in lysosomes induces selective death of cancer cells","volume":"15","author":"Borkowska","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2024.06.004_bib46","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1021\/acs.jpcb.3c04489","article-title":"Phosphatidylethanolamine and cholesterol promote hemifusion formation: a tug of war between membrane interfacial order and intrinsic negative curvature of lipids","volume":"127","author":"Mishra","year":"2023","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.apsb.2024.06.004_bib47","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1021\/acs.langmuir.2c00430","article-title":"Computational insights into the role of cholesterol in inverted hexagonal phase stabilization and endosomal drug release","volume":"38","author":"Ramezanpour","year":"2022","journal-title":"Langmuir"},{"key":"10.1016\/j.apsb.2024.06.004_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016974118","article-title":"Membrane fusion and drug delivery with carbon nanotube porins","volume":"118","author":"Ho","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.004_bib49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2013.12.007","article-title":"Enhanced endosomal\/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA","volume":"176","author":"Li","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.06.004_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn6612","article-title":"Selective STING stimulation in dendritic cells primes antitumor T cell responses","volume":"8","author":"Jneid","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.apsb.2024.06.004_bib51","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1182\/blood-2002-11-3580","article-title":"Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24","volume":"102","author":"Chiriva-Internati","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2024.06.004_bib52","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2024.06.004_bib53","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.biomaterials.2009.01.057","article-title":"The uptake and intracellular fate of PLGA nanoparticles in epithelial cells","volume":"30","author":"Cartiera","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2024.06.004_bib54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS\u2013STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2024.06.004_bib55","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41422-020-0346-1","article-title":"Old dogs, new trick: classic cancer therapies activate cGAS","volume":"30","author":"Yum","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2024.06.004_bib56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","volume":"79","author":"Yu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2024.06.004_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.apsb.2024.06.004_bib58","first-page":"73","article-title":"The untold story of IFN-\u03b3 in cancer biology","volume":"35","author":"Kursunel","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.apsb.2024.06.004_bib59","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1038\/s41467-022-30568-1","article-title":"STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.06.004_bib60","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jconrel.2022.03.056","article-title":"The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis","volume":"345","author":"Wang","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.06.004_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.567365","article-title":"Opsonins and dysopsonins of nanoparticles: facts, concepts, and methodological guidelines","volume":"11","author":"Papini","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2024.06.004_bib62","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.06.004_bib63","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1021\/acsnano.2c05917","article-title":"Nanoprobe based on biominerals in protein corona for dual-modality MR imaging and therapy of tumors","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.06.004_bib64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00693363","article-title":"Transferrin-receptor interaction and iron uptake by reticulocytes of vertebrate animals\u2014a comparative study","volume":"157","author":"Lim","year":"1987","journal-title":"J Comp Physiol B"},{"key":"10.1016\/j.apsb.2024.06.004_bib65","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.febslet.2010.06.023","article-title":"Heparin binding domain in\u00a0vitro nectin is required for oligomerization and thus enhances integrin mediated cell adhesion and spreading","volume":"584","author":"Chillakuri","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2024.06.004_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012387","article-title":"Role of vitronectin and its receptors in neuronal function and neurodegenerative diseases","volume":"23","author":"Ruzha","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.06.004_bib67","article-title":"Transferrin receptor-mediated iron uptake promotes colon tumorigenesis","volume":"10","author":"Kim","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2024.06.004_bib68","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1021\/acsomega.0c05848","article-title":"Transferrin: biology and use in receptor-targeted nanotherapy of gliomas","volume":"6","author":"Koneru","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.apsb.2024.06.004_bib69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin alpha v beta 3 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.06.004_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300351","article-title":"Recent advances of emerging spleen-targeting nanovaccines for immunotherapy","volume":"12","author":"He","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.apsb.2024.06.004_bib71","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2024.06.004_bib72","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","article-title":"Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy","volume":"27","author":"Pitt","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2024.06.004_bib73","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","article-title":"The spleen in local and systemic regulation of immunity","volume":"39","author":"Bronte","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2024.06.004_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188704","article-title":"Tumor draining lymph nodes, immune response, and radiotherapy: towards a revisal of therapeutic principles","volume":"1877","author":"Koukourakis","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.apsb.2024.06.004_bib75","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Sistigu","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2024.06.004_bib76","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","article-title":"Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T Cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2024.06.004_bib77","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.23.021704.115723","article-title":"Maintenance of serum antibody levels","volume":"23","author":"Manz","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.apsb.2024.06.004_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","article-title":"Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment","volume":"12","author":"Yang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2024.06.004_bib79","first-page":"641","article-title":"Lipid nanoparticle-mediated CRISPR\/Cas9 gene editing and metabolic engineering for anticancer immunotherapy","volume":"17","author":"Ju","year":"2022","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.apsb.2024.06.004_bib80","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1172\/JCI80006","article-title":"Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages","volume":"125","author":"Ugel","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2024.06.004_bib81","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","article-title":"Macrophages and cancer: from mechanisms to therapeutic implications","volume":"36","author":"Ostuni","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2024.06.004_bib82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.addr.2014.09.007","article-title":"Targeting myeloid cells using nanoparticles to improve cancer immunotherapy","volume":"91","author":"Amoozgar","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2024.06.004_bib83","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006481","article-title":"Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL\/4-1BB co-stimulation","volume":"11","author":"Sun","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2024.06.004_bib84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524002351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524002351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:18:47Z","timestamp":1762604327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524002351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2211383524002351"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.06.004","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous delivery of STING agonists using acid-sensitive polycationic polymer-modified lipid nanoparticles for enhanced tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}